FDA guideline on BE, draft August 2021 [BE/BA News]

posted by Achievwin – US, 2021-08-23 23:35 (521 d 06:52 ago) – Posting: # 22534
Views: 2,163

❝ FDA updated the canonical BE guideline for ANDAs. Draft. :-)


Comments period is open till October 22, 2021, Therefore any issues bothering/benefit ANDA folks can be sent to FDA as comments for consideration.

FDA decided to split BA/BE guidance into two guidance 1) for ANDA filings and 2) for IND/NDAs

More elaborate explanations of each aspect.

Complete thread:

UA Flag
Activity
 Admin contact
22,477 posts in 4,708 threads, 1,603 registered users;
14 visitors (0 registered, 14 guests [including 7 identified bots]).
Forum time: 05:28 CET (Europe/Vienna)

In these matters the only certainty is
that nothing is certain.    Pliny the Elder

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5